AURKA is a prognostic potential therapeutic target in skin cutaneous melanoma modulating the tumor microenvironment, apoptosis, and hypoxia

  • Aran D, Hu Z, Butte AJ (2017) xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol 18(1):220. doi.org/10.1186/s13059-017-1349-1

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bajor DL, Mick R, Riese MJ, Huang AC, Sullivan B, Richman LP, Torigian DA, George SM, Stelekati E, Chen F, Melenhorst JJ, Lacey SF, Xu X, Wherry EJ, Gangadhar TC, Amaravadi RK, Schuchter LM, Vonderheide RH (2018) Long-term outcomes of a phase I study of agonist CD40 antibody and CTLA-4 blockade in patients with metastatic melanoma. Oncoimmunology 7(10):e1468956. doi.org/10.1080/2162402x.2018.1468956

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, Selves J, Laurent-Puig P, Sautès-Fridman C, Fridman WH, de Reyniès A (2016) Erratum to: Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol 17(1):249. doi.org/10.1186/s13059-016-1113-y

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, Angell H, Fredriksen T, Lafontaine L, Berger A, Bruneval P, Fridman WH, Becker C, Pagès F, Speicher MR, Trajanoski Z, Galon J (2013) Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39(4):782–795. doi.org/10.1016/j.immuni.2013.10.003

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Binnewies M, Roberts EW, Kersten K, Chan V (2018) Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med 24(5):541–550. doi.org/10.1038/s41591-018-0014-x

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Caputo E, Miceli R, Motti ML, Taté R, Fratangelo F, Botti G, Mozzillo N, Carriero MV, Cavalcanti E, Palmieri G, Ciliberto G, Pirozzi G, Ascierto PA (2014) AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment. J Transl Med 12:216. doi.org/10.1186/s12967-014-0216-z

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chen ML, Pittet MJ, Gorelik L, Flavell RA, Weissleder R, von Boehmer H, Khazaie K (2005) Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc Natl Acad Sci USA 102(2):419–424. doi.org/10.1073/pnas.0408197102

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • D’Assoro AB, Liu T, Quatraro C, Amato A, Opyrchal M, Leontovich A, Ikeda Y, Ohmine S, Lingle W, Suman V, Ecsedy J, Iankov I, Di Leonardo A, Ayers-Inglers J, Degnim A, Billadeau D, McCubrey J, Ingle J, Salisbury JL, Galanis E (2014) The mitotic kinase Aurora–a promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα(+) breast cancer cells. Oncogene 33(5):599–610. doi.org/10.1038/onc.2012.628

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • de Souza VB, Kawano DF (2020) Structural basis for the design of allosteric inhibitors of the Aurora kinase A enzyme in the cancer chemotherapy. Biochim Biophys Acta 1:129448. doi.org/10.1016/j.bbagen.2019.129448

    CAS 
    Article 

    Google Scholar
     

  • Doncheva NT, Morris JH (2019) Cytoscape StringApp: network analysis and visualization of proteomics data. J Proteome Res 18(2):623–632. doi.org/10.1021/acs.jproteome.8b00702

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Flaherty KT, Hodi FS, Fisher DE (2012) From genes to drugs: targeted strategies for melanoma. Nat Rev Cancer 12(5):349–361. doi.org/10.1038/nrc3218

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Garnis C, Buys TP, Lam WL (2004) Genetic alteration and gene expression modulation during cancer progression. Mol Cancer 3:9. doi.org/10.1186/1476-4598-3-9

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Gide TN, Wilmott JS, Scolyer RA, Long GV (2018) Primary and acquired resistance to immune checkpoint inhibitors in metastatic melanoma. Clin Cancer Res 24(6):1260–1270. doi.org/10.1158/1078-0432.ccr-17-2267

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Goos JA, Coupe VM, Diosdado B, Delis-Van Diemen PM, Karga C, Beliën JA, Carvalho B, van den Tol MP, Verheul HM, Geldof AA, Meijer GA, Hoekstra OS, Fijneman RJ (2013) Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis. Br J Cancer 109(9):2445–2452. doi.org/10.1038/bjc.2013.608

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Guo M, Lu S, Huang H, Wang Y, Yang MQ, Yang Y, Fan Z, Jiang B, Deng Y (2018) Increased AURKA promotes cell proliferation and predicts poor prognosis in bladder cancer. BMC Syst Biol 12(Suppl 7):118. doi.org/10.1186/s12918-018-0634-2

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Hahn WC, Weinberg RA (2002) Rules for making human tumor cells. N Engl J Med 347(20):1593–1603. doi.org/10.1056/NEJMra021902

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674. doi.org/10.1016/j.cell.2011.02.013

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Jhunjhunwala S, Hammer C (2021) Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion. Nat Rev Cancer 21(5):298–312. doi.org/10.1038/s41568-021-00339-z

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Kalaora S, Nagler A, Wargo JA (2022) Mechanisms of immune activation and regulation: lessons from melanoma. Nat Rev Cancer. doi.org/10.1038/s41568-022-00442-9

    Article 
    PubMed 

    Google Scholar
     

  • Keirsse J, Van Damme H, Van Ginderachter JA, Laoui D (2017) Exploiting tumor-associated dendritic cell heterogeneity for novel cancer therapies. J Leukoc Biol 102(2):317–324. doi.org/10.1189/jlb.4MR1116-466R

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Korn T, Bettelli E, Oukka M, Kuchroo VK (2009) IL-17 and Th17 cells. Annu Rev Immunol 27:485–517. doi.org/10.1146/annurev.immunol.021908.132710

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Li MO, Flavell RA (2008) TGF-beta: a master of all T cell trades. Cell 134(3):392–404. doi.org/10.1016/j.cell.2008.07.025

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS (2020) TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res 48(W1):W509-w514. doi.org/10.1093/nar/gkaa407

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Linares MA, Zakaria A, Nizran P (2015) Skin cancer. Prim Care 42(4):645–659. doi.org/10.1016/j.pop.2015.07.006

    Article 
    PubMed 

    Google Scholar
     

  • Liu ZG, Yi W, Tao YL, Chan HC, Zeng MS, Xia YF (2012) Aurora-A is an efficient marker for predicting poor prognosis in human nasopharyngeal carcinoma with aggressive local invasion: 208 cases with a 10-year follow-up from a single institution. Oncol Lett 3(6):1237–1244. doi.org/10.3892/ol.2012.660

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Liu CJ, Hu FF, Xia MX, Han L, Zhang Q, Guo AY (2018) GSCALite: a web server for gene set cancer analysis. Bioinformatics (oxford, England) 34(21):3771–3772. doi.org/10.1093/bioinformatics/bty411

    CAS 
    Article 

    Google Scholar
     

  • Malta TM, Sokolov A, Gentles AJ, Burzykowski T, Poisson L, Weinstein JN, Kamińska B, Huelsken J, Omberg L, Gevaert O, Colaprico A, Czerwińska P, Mazurek S, Mishra L, Heyn H, Krasnitz A, Godwin AK, Lazar AJ, Stuart JM, Hoadley KA, Laird PW, Noushmehr H, Wiznerowicz M (2018) Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell 173(2):338-354.e315. doi.org/10.1016/j.cell.2018.03.034

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Mehdi A, Rabbani SA (2021) Role of methylation in pro- and anti-cancer immunity. Cancers. doi.org/10.3390/cancers13030545

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Modhukur V, Iljasenko T, Metsalu T, Lokk K, Laisk-Podar T, Vilo J (2018) MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data. Epigenomics 10(3):277–288. doi.org/10.2217/epi-2017-0118

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Nagy Á, Győrffy B (2021) muTarget: a platform linking gene expression changes and mutation status in solid tumors. Int J Cancer 148(2):502–511. doi.org/10.1002/ijc.33283

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Pandey PR, Young KH, Kumar D (2022) RNA-mediated immunotherapy regulating tumor immune microenvironment: next wave of cancer therapeutics. Mol Cancer 21(1):58. doi.org/10.1186/s12943-022-01528-6

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Panicker RC, Coyne AG, Srinivasan R (2019) Allosteric targeting of Aurora A kinase using small molecules: a step forward towards next generation medicines? Curr Med Chem 26(13):2234–2242. doi.org/10.2174/0929867324666170727120315

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Puig-Butille JA, Vinyals A, Ferreres JR, Aguilera P, Cabré E, Tell-Martí G, Marcoval J, Mateo F, Palomero L, Badenas C, Piulats JM, Malvehy J, Pujana MA, Puig S, Fabra À (2017) AURKA overexpression is driven by FOXM1 and MAPK/ERK activation in melanoma cells harboring BRAF or NRAS mutations: impact on melanoma prognosis and therapy. J Invest Dermatol 137(6):1297–1310. doi.org/10.1016/j.jid.2017.01.021

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Punt S, Malu S, McKenzie JA, Manrique SZ, Doorduijn EM, Mbofung RM, Williams L, Silverman DA, Ashkin EL, Dominguez AL, Wang Z, Chen JQ, Maiti SN, Tieu TN, Liu C, Xu C, Forget MA, Haymaker C, Khalili JS, Satani N, Muller F, Cooper LJN, Overwijk WW, Amaria RN, Bernatchez C, Heffernan TP, Peng W, Roszik J, Hwu P (2021) Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity. Cancer Immunol Immunother 70(4):1101–1113. doi.org/10.1007/s00262-020-02748-9

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Rakhra K, Bachireddy P, Zabuawala T, Zeiser R, Xu L, Kopelman A, Fan AC, Yang Q, Braunstein L, Crosby E, Ryeom S, Felsher DW (2010) CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation. Cancer Cell 18(5):485–498. doi.org/10.1016/j.ccr.2010.10.002

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Scarpini S, Rouprêt M, Renard-Penna R, Camparo P, Cussenot O, Compérat E (2012) Impact of the expression of Aurora-A, p53, and MIB-1 on the prognosis of urothelial carcinomas of the upper urinary tract. Urol Oncol 30(2):182–187. doi.org/10.1016/j.urolonc.2009.12.003

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Schadendorf D, van Akkooi ACJ, Berking C, Griewank KG, Gutzmer R, Hauschild A, Stang A, Roesch A, Ugurel S (2018) Melanoma. Lancet (london, England) 392(10151):971–984. doi.org/10.1016/s0140-6736(18)31559-9

    Article 

    Google Scholar
     

  • Scharping NE, Rivadeneira DB, Menk AV, Vignali PDA, Ford BR, Rittenhouse NL, Peralta R, Wang Y, Wang Y, DePeaux K (2021) Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion. Nat Immunol 22(2):205–215. doi.org/10.1038/s41590-020-00834-9

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Seoane J, Gomis RR (2017) TGF-β family signaling in tumor suppression and cancer progression. Cold Spring Harbor Perspect Biol. doi.org/10.1101/cshperspect.a022277

    Article 

    Google Scholar
     

  • Siegel RL, Miller KD (2019) Cancer statistics. CA A Cancer J Clin 69(1):7–34. doi.org/10.3322/caac.21551

    Article 

    Google Scholar
     

  • Sturm G, Finotello F, Petitprez F, Zhang JD, Baumbach J, Fridman WH, List M, Aneichyk T (2019) Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology. Bioinformatics (oxford, England) 35(14):i436–i445. doi.org/10.1093/bioinformatics/btz363

    CAS 
    Article 

    Google Scholar
     

  • Umene K, Yanokura M, Banno K, Irie H, Adachi M, Iida M, Nakamura K, Nogami Y, Masuda K, Kobayashi Y, Tominaga E, Aoki D (2015) Aurora kinase A has a significant role as a therapeutic target and clinical biomarker in endometrial cancer. Int J Oncol 46(4):1498–1506. doi.org/10.3892/ijo.2015.2842

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Vilgelm AE, Johnson CA, Prasad N, Yang J, Chen SC, Ayers GD, Pawlikowski JS, Raman D, Sosman JA, Kelley M, Ecsedy JA, Shyr Y, Levy SE, Richmond A (2016) Connecting the dots: therapy-induced senescence and a tumor-suppressive immune microenvironment. J Natl Cancer Inst. doi.org/10.1093/jnci/djv406

    Article 
    PubMed 

    Google Scholar
     

  • Wang M, Ngo V, Wang W (2021) Deciphering the genetic code of DNA methylation. Brief Bioinform. doi.org/10.1093/bib/bbaa424

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Xu J, Wu X, Zhou WH, Liu AW, Wu JB, Deng JY, Yue CF, Yang SB, Wang J, Yuan ZY, Liu Q (2013) Aurora-A identifies early recurrence and poor prognosis and promises a potential therapeutic target in triple negative breast cancer. PLoS ONE 8(2):e56919. doi.org/10.1371/journal.pone.0056919

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Yan M, Wang C, He B, Yang M, Tong M, Long Z, Liu B, Peng F, Xu L, Zhang Y, Liang D, Lei H, Subrata S, Kelley KW, Lam EW, Jin B, Liu Q (2016) Aurora-A kinase: a potent oncogene and target for cancer therapy. Med Res Rev 36(6):1036–1079. doi.org/10.1002/med.21399

    Article 
    PubMed 

    Google Scholar
     

  • Yoshihara K, Shahmoradgoli M, Martínez E, Vegesna R, Kim H, Torres-Garcia W, Treviño V, Shen H, Laird PW, Levine DA, Carter SL, Getz G, Stemke-Hale K, Mills GB, Verhaak RG (2013) Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 4:2612. doi.org/10.1038/ncomms3612

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Yuan H, Yan M, Zhang G, Liu W, Deng C, Liao G, Xu L, Luo T, Yan H, Long Z, Shi A, Zhao T, Xiao Y, Li X (2019) CancerSEA: a cancer single-cell state atlas. Nucleic Acids Res 47(D1):D900-d908. doi.org/10.1093/nar/gky939

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Zhang Y, Zhang Z (2020) The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol 17(8):807–821. doi.org/10.1038/s41423-020-0488-6

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Read more here: Source link